George A. Eldridge - Dec 7, 2022 Form 4 Insider Report for Aerovate Therapeutics, Inc. (AVTE)

Role
Officer Title: Chief Financial Officer and Treasurer
Signature
/s/ George A. Eldridge
Stock symbol
AVTE
Transactions as of
Dec 7, 2022
Transactions value $
-$466,176
Form type
4
Date filed
12/9/2022, 05:00 PM
Previous filing
Dec 2, 2022
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTE Common Stock Options Exercise $24.9K +11.6K +593.72% $2.14* 13.6K Dec 7, 2022 Direct F1
transaction AVTE Common Stock Sale -$137K -7.08K -52.06% $19.37 6.52K Dec 7, 2022 Direct F1, F2
transaction AVTE Common Stock Sale -$93K -4.56K -69.93% $20.40 1.96K Dec 7, 2022 Direct F1, F3
transaction AVTE Common Stock Options Exercise $25.7K +12K +612.81% $2.14* 14K Dec 8, 2022 Direct F1
transaction AVTE Common Stock Sale -$19.3K -960 -6.87% $20.12 13K Dec 8, 2022 Direct F1, F4
transaction AVTE Common Stock Sale -$412 -20 -0.15% $20.58 13K Dec 8, 2022 Direct F1
transaction AVTE Common Stock Sale -$267K -11K -84.91% $24.20 1.96K Dec 8, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -11.6K -12.08% $0.00 84.7K Dec 7, 2022 Common Stock 11.6K $2.14 Direct F1, F6
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -1.89K -2.23% $0.00 82.8K Dec 8, 2022 Common Stock 1.89K $2.14 Direct F1, F6
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -10.1K -19.91% $0.00 40.7K Dec 8, 2022 Common Stock 10.1K $2.14 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.97, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.02 to $20.56, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.575 to $20.54, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6 A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.
F7 A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Remarks:

Officer Title: Chief Financial Officer and Treasurer